| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 337.175 | 717.375 | 18.490 | 66.578 | 31.972 | 140.343 | 47.640 | 38.384 | 121.015 | 63.388 |
| Total Expenses - EUR | 103.601 | 152.851 | 18.988 | 13.278 | 161.033 | 8.846 | 2.027 | 2.598 | 11.792 | 14.478 |
| Gross Profit/Loss - EUR | 233.574 | 564.524 | -498 | 53.299 | -129.061 | 131.497 | 45.613 | 35.786 | 109.223 | 48.910 |
| Net Profit/Loss - EUR | 201.035 | 474.715 | -647 | 53.120 | -129.061 | 121.859 | 45.215 | 35.514 | 108.334 | 48.276 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Squaremedical S.a.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.195.233 | 744.652 | 385.003 | 376.290 | 216.992 | 207.144 | 203.081 | 204.222 | 203.660 | 200.075 |
| Current Assets | 694.572 | 1.571.094 | 301.301 | 226.938 | 241.878 | 314.623 | 343.426 | 308.243 | 314.181 | 261.735 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 267.371 | 213.058 | 204.333 | 203.386 | 199.451 | 274.263 | 190.906 | 229.954 | 192.260 | 190.393 |
| Cash | 427.201 | 1.358.037 | 96.968 | 23.552 | 42.426 | 40.360 | 152.519 | 78.289 | 121.921 | 71.342 |
| Shareholders Funds | 1.849.342 | 2.306.937 | 624.961 | 537.676 | 398.202 | 512.512 | 546.361 | 442.759 | 484.728 | 442.389 |
| Social Capital | 1.424.697 | 1.410.167 | 116.631 | 114.490 | 112.273 | 110.145 | 107.702 | 108.036 | 107.708 | 102.420 |
| Debts | 40.463 | 8.810 | 61.343 | 65.552 | 60.667 | 9.255 | 145 | 69.707 | 33.113 | 19.422 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Squaremedical S.a.